Follow-up
NRS, pain
TSS
Recall visits were scheduled after 3 and 6 months of sleep splint therapy. The same variables were assessed as at baseline: TMD symptoms #1–6 (TSS), subjective pain intensity (NRS) and the impact of the occlusal splint therapy on the patient’s QoL. The clinical examinations at the recall visits were performed by a second experienced dentist, who was blinded to the type of MMR registration method. For all palpation procedures, inter-examiner reliability was achieved by calibrating finger pressure with a force-measuring device (AFP 3100L, AE Adam GmbH, Felde, Germany) according to a previously described protocol